IMU Share Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month 0.00 0.00
Volume 492697 1 Year 0.00 0.00
52 Week High 0.02
52 Week Low 0.01
IMU Important Levels
Resistance 2 0.01
Resistance 1 0.01
Pivot 0.01
Support 1 0.01
Support 2 0.01
ASX Australia Most Active Stocks
KAS 0.02 100.00%
KAS 0.02 100.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TLS 4.34 0.46%
TLS 4.34 0.46%
TLS 4.34 0.46%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
KAS 0.02 100.00%
KAS 0.02 100.00%
NGY 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
BNV 0.03 50.00%
PMQ 0.03 50.00%
ANP 0.04 33.33%
More..
ASX Australia Top Losers Stocks
SER 0.00 -100.00%
SER 0.00 -100.00%
RMI 0.00 -100.00%
RMI 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
AVI 0.01 -50.00%
More..

Imugene Ltd (ASX: IMU)

IMU Technical Analysis 5
As on 26th Jun 2017 IMU Share Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.01 & Strong Sell for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
IMU Target for June
1st Target up-side 0.02
2nd Target up-side 0.02
3rd Target up-side 0.02
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side -0
IMU Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.imugene.com
IMU Address
IMU
1233 High Street
Suite 1
Armadale, VIC 3143
Australia
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
IMU Latest News
Trading Monitor: What's Next For Imugene Ltd (IMU.AX)?   Providence Standard   - 26th Jun 17
Will Imugene's expertise in immunotherapies result in an AstraZeneca type ...   Finfeed   - 17th May 17
Clinical studies could provide market moving news for Immuron in 2017   Finfeed   - 07th Apr 17
Support from leading institutional investors augurs well for Imugene   Finfeed   - 07th Apr 17
Imugene receives investor support   NEWS.com.au   - 30th Mar 17
Imugene Limited (ASX:IMU) Encouraging HER-Vaxx Research Published in ...   ABN Newswire (press release)   - 13th Feb 17
Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine ...   BMC Blogs Network   - 10th Feb 17
Imugene gets immuno-oncology tech   NEWS.com.au   - 13th Dec 16
4 small biotech stocks for your watchlist   Motley Fool Australia   - 27th Oct 14
Imugene to Acquire Biolife Science Qld Limited   Business Wire (press release)   - 23rd Oct 13
Interactive Technical Analysis Chart Imugene Ltd ( IMU ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Imugene Ltd
IMU Business Profile
Imugene Limited, a pharmaceutical company, is engaged in the research, development, and commercialization of health technologies in Australia. The company’s drug delivery platform technology, Linguet enables the active ingredient of drugs to be absorbed into the bloodstream when placed inside the cheek or under the tongue for the treatment of Vitamin D deficiency, Parkinson’s disease, osteoporosis, pain relief markets of non-steroidal anti-inflammatory drugs. The company is also involved in the development of Vitamin D tablet for buccal delivery; and lead cancer vaccine product targeting gastric cancer and breast cancer. Imugene Limited is based in Armadale, Australia.